Acute GvHD: pathogenesis and classification (Q37188484)

18 August 2017

1 reference

title

Acute GvHD: pathogenesis and classification (English)

1 reference

18 August 2017

0 references

L M Ball

1

1 reference

18 August 2017

R M Egeler

series ordinal

2

1 reference

18 August 2017

EBMT Paediatric Working Party

series ordinal

3

1 reference

18 August 2017

language of work or name

English

0 references

publication date

1 June 2008

1 reference

Bone Marrow Transplantation

18 August 2017

1 reference

18 August 2017

41 Suppl 2

1 reference

18 August 2017

S58-64

1 reference

https://scigraph.springernature.com/pub.10.1038/bmt.2008.56

18 August 2017

0 references

cites work

Acute graft-versus-host disease: pathophysiology, clinical manifestations, and management.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.56

Acute graft-vs-host disease: pathobiology and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.56

Nonmyeloablative allogeneic stem cell transplantation: early promise and limitations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.56

The toxicity and efficacy of donor lymphocyte infusions given after reduced-intensity conditioning allogeneic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.56

Minimal GVHD following in-vitro Tcell–depleted allogeneic stem cell transplantation with reduced-intensity conditioning allowing subsequent infusions of donor lymphocytes in patients with hematological malignancies and solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.56

Dose-escalated donor lymphocyte infusions following reduced intensity transplantation: toxicity, chimerism, and disease responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.56

Reduced intensity conditioning and prophylactic DLI can cure patients with high-risk acute leukaemias if complete donor chimerism can be achieved

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.56

Increasing mixed chimerism is an important prognostic factor for unfavorable outcome in children with acute lymphoblastic leukemia after allogeneic stem-cell transplantation: possible role for pre-emptive immunotherapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.56

The minor histocompatibility antigen HA-1: a diallelic gene with a single amino acid polymorphism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.56

A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.56

Both donor and recipient NOD2/CARD15 mutations associate with transplant-related mortality and GvHD following allogeneic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.56

New directions in the genomics of allogeneic hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.56

Prediction of graft-versus-host disease in humans by donor gene-expression profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.56

Donor methylenetetrahydrofolate reductase genotype is associated with graft-versus-host disease in hematopoietic stem cell transplant patients treated with methotrexate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.56

Methylenetetrahydrofolate reductase and thymidylate synthase genotypes and risk of acute graft-versus-host disease following hematopoietic cell transplantation for chronic myelogenous leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.56

Immunopathogenesis of acute graft-versus-host disease: implications for novel preventive and therapeutic strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.56

Critical role of interleukin-2 in the development of acute graft-versus-host disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.56

Accumulation and activation-induced release of preformed Fas (CD95) ligand during the pathogenesis of experimental graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.56

APCs in the liver and spleen recruit activated allogeneic CD8+ T cells to elicit hepatic graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.56

CD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.56

Partial CD8+ T-cell depletion of allogeneic peripheral blood stem cell transplantation is insufficient to prevent graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.56

Human CD4(+)CD25(+) regulatory, contact-dependent T cells induce interleukin 10-producing, contact-independent type 1-like regulatory T cells [corrected].

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.56

Cell contact-dependent immunosuppression by CD4(+)CD25(+) regulatory T cells is mediated by cell surface-bound transforming growth factor beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.56

CD25 expression on donor CD4+ or CD8+ T cells is associated with an increased risk for graft-versus-host disease after HLA-identical stem cell transplantation in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.56

Host dendritic cells alone are sufficient to initiate acute graft-versus-host disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.56

A possible role for CCL27/CTACK-CCR10 interaction in recruiting CD4 T cells to skin in human graft-versus-host disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.56

Marrow transplantation from related donors other than HLA-identical siblings

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.56

An acute graft-versus-host disease activity index to predict survival after hematopoietic cell transplantation with myeloablative conditioning regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.56

Smarter rather than stronger treatment of haematological malignancies and non-malignant indications for stem-cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.56

7 January 2021

Mismatches of minor histocompatibility antigens between HLA-identical donors and recipients and the development of graft-versus-host disease after bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.56

7 January 2021

Non-HLA immunogenetics in hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.56

7 January 2021

Prognostic significance of NOD2/CARD15 variants in HLA-identical sibling hematopoietic stem cell transplantation: effect on long-term outcome is confirmed in 2 independent cohorts and may be modulated by the type of gastrointestinal decontamination

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.56

7 January 2021

The Pathophysiology of Acute Graft-versus-Host Disease

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.56

7 January 2021

Inflammatory cytokines and acute graft-versus-host disease after reduced-intensity conditioning allogeneic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.56

7 January 2021

Differential use of Fas ligand and perforin cytotoxic pathways by donor T cells in graft-versus-host disease and graft-versus-leukemia effect

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.56

7 January 2021

Donor T cell-derived TNF is required for graft-versus-host disease and graft-versus-tumor activity after bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.56

7 January 2021

Chronic graft-versus-host disease is associated with increased numbers of peripheral blood CD4+CD25high regulatory T cells

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.56

7 January 2021

Prevention of graft versus host disease by inactivation of host antigen-presenting cells

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.56

7 January 2021

Donor APCs are required for maximal GVHD but not for GVL

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.56

7 January 2021

Expression of chemokines in GVHD target organs is influenced by conditioning and genetic factors and amplified by GVHR

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.56

7 January 2021

Risk factors for acute graft-versus-host disease in histocompatible donor bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.56

7 January 2021

Donor characteristics as risk factors in recipients after transplantation of bone marrow from unrelated donors: the effect of donor age

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.56

7 January 2021

Acute and chronic graft-versus-host disease after allogeneic peripheral-blood stem-cell and bone marrow transplantation: a meta-analysis

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.56

7 January 2021

Identifiers

DOI

10.1038/BMT.2008.56

1 reference

18 August 2017

1 reference